Singapore markets open in 2 hours 15 minutes

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.1500-0.0700 (-3.15%)
At close: 03:51PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.2200
Open2.2550
BidN/A x N/A
AskN/A x N/A
Day's range2.1100 - 2.2550
52-week range1.5400 - 7.7600
Volume19,679
Avg. volume16,688
Market cap42.371M
Beta (5Y monthly)1.12
PE ratio (TTM)N/A
EPS (TTM)-1.1230
Earnings date28 Feb 2022 - 04 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.00
  • CNW Group

    Medexus Virtually Opens The Market

    Ken D'Entremont, Chief Executive Officer, Medexus Pharmaceuticals Inc., ("Medexus" or the "Company") (TSX: MDP), and his team joined Daniel Lubienietzky, Manager, Life Sciences, TMX Group, to celebrate the Company's new listing on Toronto Stock Exchange and open the market.

  • CNW Group

    Sunquest Lauded by Frost & Sullivan for Driving Efficiency and Compliance with Its Differentiated Molecular Laboratory Information Management System

    Sunquest provides various interoperable products and services that work with each other to improve lab efficiency and results accuracyLONDON, March 2, 2021 /CNW/ -- Based on its recent analysis of the North American laboratory information management systems (LIMS) market for molecular and genetic diagnostics, Frost & Sullivan recognizes Sunquest Information Systems with the 2021 North America Company of the Year Award. Sunquest's comprehensive portfolio of products and services improves operational efficiency, enhances patient care, and lowers healthcare organizations' costs across the spectrum.

  • CNW Group

    IIROC Trading Resumption - MDP

    3, 2021 /CNW/ - Trading resumes in: Company: Medexus Pharmaceuticals Inc.TSX-Venture Symbol: MDPAll Issues: YesResumption (ET): 11:00 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.